Inhibrx Biosciences, Inc. (INBX)
123.34
-0.59
(-0.48%)
USD |
NASDAQ |
Aug 28, 16:00
123.34
0.00 (0.00%)
After-Hours: 20:00
Inhibrx Biosciences Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2025 | 49.08% |
| March 31, 2025 | |
| December 31, 2024 | -589.0% |
| September 30, 2024 | |
| June 30, 2024 | -375.0% |
| Date | Value |
|---|---|
| March 31, 2024 | |
| December 31, 2023 | 81.76% |
| September 30, 2023 | -155.5% |
| June 30, 2023 | -883.3% |
| March 31, 2023 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| AnaptysBio, Inc. | 97.61% |
| 4D Molecular Therapeutics, Inc. | 44.75% |
| Design Therapeutics, Inc. | -- |
| Agenus, Inc. | 98.50% |
| Amgen, Inc. | 72.08% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -1.75K% |
| Return on Assets | -79.03% |
| Return on Invested Capital | -95.61% |
| Return on Net Operating Assets | -807.2% |